PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
-40.91%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$93.7M
AUM Growth
+$93.7M
(-53%)
Cap. Flow
-$8.34M
Cap. Flow
% of AUM
-8.9%
Top 10 Holdings %
Top 10 Hldgs %
99.15%
Holding
12
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Fate Therapeutics
FATE
|
$8.34M |
Sector Composition
| 1 | Healthcare | 64.57% |
| 2 | Communication Services | 29.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Cardlytics
CDLX
$54.3M
| $27.6M | 29.51% |
2,552,626
| – | – |
|
|
2
Fate Therapeutics
FATE
$120M
| $23.4M | 24.97% |
1,823,186
-650,000
| -26% | -$8.34M |
|
3
Neuronetics
STIM
$220M
| $16M | 17.04% |
824,765
| – | – |
|
4
KALA BIO
KALA
$78.8M
| $9.08M | 9.7% |
1,857,582
| – | – |
|
|
TTOO
5
DELISTED
T2 Biosystems, Inc
TTOO
| $5.54M | 5.92% |
1,841,924
| – | – |
|
6
X4 Pharmaceuticals
XFOR
$84.2M
| $4.34M | 4.63% |
1,868,957
| – | – |
|
7
Cartesian Therapeutics
RNAC
$261M
| $4.27M | 4.56% |
1,606,813
| – | – |
|
|
ATYR
8
aTyr Pharma
ATYR
$527M
| $906K | 0.97% |
1,827,992
| – | – |
|
|
TRVN
9
DELISTED
Trevena, Inc.
TRVN
| $883K | 0.94% |
2,053,540
| – | – |
|
10
Pulmatrix
PULM
$18M
| $863K | 0.92% |
3,594,381
| – | – |
|
|
GNCA
11
DELISTED
Genocea Biosciences, Inc.
GNCA
| $565K | 0.6% |
1,968,606
| – | – |
|
12
Dare Bioscience
DARE
$27.2M
| $232K | 0.25% |
326,243
| – | – |
|